The global apheresis market size is estimated to grow USD 3.54 billion by 2026 from USD 2.2 billion in 2021, showcasing a CAGR of 9.96% during the forecast period.
Apheresis removes the blood from the donor or patient and sends it to an apparatus that separates one particular constituent and returns the remainder to the body. The procedure involves connecting the blood in the patient's vein through tubing to a machine that separates the blood components. After the separation, the desired blood component is taken, while the rest of the blood components are reinforced back into the patient.
MARKET DRIVERS:
In recent years, apheresis procedures have observed a rise in the number and areas of applications, and the apheresis market for these procedures continues to increase at an unprecedented pace. Currently, apheresis procedures are used as a part of treatment in various renal diseases, neurology, cancer, hematology, autoimmune diseases, and cardiovascular diseases. Several private and public insurers have begun to observe the apheresis reimbursement procedure. Many private insurers provide coverage for apheresis procedures regardless of whether they are conducted in a hospital. Similar policy-related reforms are implemented in other countries and insurers consensus on wide coverage of diseases.
Rising prevalence of various blood disorders and the growing number of trauma and injury cases, the increasing demand for blood components, and growing concerns regarding blood safety across the globe, increasing demand for source plasma from biopharmaceutical companies increasing the number of surgical procedures and emergency care cases in hospitals. The presence of favorable government initiatives and reimbursement framework is also expected to boost demand during the forecast period.
MARKET RESTRAINTS:
However, the growth of the global apheresis market is restrained by the lack of awareness about apheresis, a limited number of skilled professionals, and the high cost of these procedures.
Impact of COVID-19 on the global apheresis market:
The outrage of recent coronavirus (COVID 19) has led to significant and rapid healthcare industry changes. The World Health Organization (WHO) announced the pandemic as public health emergency issue. Many of the hospitals and clinics have shut their doors temporarily during the lockdown period. The medical professionals who are in the front line battling the COVID 19 need to take precautionary measures to prevent the disease's spread. The COVID-19 has negatively impacted the apheresis market growth during the first half of the pandemic situation. Amidst the crisis, none of the patients have visited the hospitals and clinics to be safe and protect themselves from the virus. The professionals have taken severe measures to collect any blood components from patients or donors to avoid the infection. The healthcare professionals have re-started their work in organizing blood either from the patients or donors that may be used during emergencies. The apheresis market has increased the revenue by resuming their activities by performing surgical procedures.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2020 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Segments Analysed |
By Product, Procedure, Application, Technology, End User, and Region |
|
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa |
This research report on the global apheresis market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2025.
Apheresis Market - By Product:
The disposable segment is predicted to lead the global apheresis market during the forecast period based on the product. Many advancements in the manufacturing of blood bags, tubing, and disposable kits are expected to fuel the market demand. The escalating efficacy in the ability to separate all types of blood components via the therapeutic procedure is another favorable factor for the growth of the segment.
Apheresis Market - By Procedure:
Based on the procedure, the therapeutic apheresis segment is projected to register a healthy growth rate due to the growing therapeutic use for different neurology, blood, and renal diseases, increasing incidence of blood disorders, and acceptable reimbursement policies for apheresis methods.
Apheresis Market – By Application:
Based on the application, the neurology segment is expected to account for the largest share in the market during the forecast period due to the benefits associated, such as low blood loss and reduced treatment duration, and complete automation.
The hematology segment is estimated to grow at the fastest rate due to the increasing stress of hematology occurrence.
Apheresis Market – By Technology:
Based on the technology, the centrifuge apheresis segment is the most lucrative. The primary usage of centrifuges majorly drives this segment's growth for the preparation of blood components like packed red blood cells and fresh frozen plasma.
The membrane separation to have the quickest growing segment requires less time and prevents lessening of blood coagulation factors, limiting the demand for replacement fluids.
Apheresis Market – By End User:
Based on the end-user, the private and public blood collection centers segment is expected to dominate the market. The increasing number of blood component donations, growing blood centers, and rising awareness of blood collection are majorly supporting the market growth.
Apheresis Market – By Region:
Geographically, North America outranked all the other regions and was accounted majority share in the global apheresis market in 2019. It is forecasted that North American will be continuing leading the market throughout the forecast period. The large share of this region can be attributed to the presence of developed healthcare systems in the U.S. & Canada, increasing applications of apheresis products in plasma collection and fractionation, the presence of established distribution channels, and growing focus on apheresis blood collection to overcome blood shortage.
Europe and Asia-Pacific follow North America. The Asia Pacific is the fastest-growing market because countries such as Japan and emerging economies such as India and China are projected to witness exponential growth during the forecast period. Plasmapheresis accounted for the largest share of about 50.0% of the overall procedure market in 2016. In Application, neurology is expected to witness the fastest growth. In Technology, centrifugation held the majority shares. However, over the forecast period, membrane filtration is predicted to register more growth.
KEY MARKET PARTICIPANTS:
Some of the companies that are playing a dominating role in the global apheresis market profiled in the report are Asahi Kasei Medical Co., Ltd., Haemonetics Corporation, Terumo BCT, Inc., Fresenius Medical Care, Kawasumi Laboratories Inc., Cerus Corporation, HemaCare Corporation, Kaneka Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd., Therakos, Inc., and Medica S.p.A.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Apheresis devices
5.1.2.1 Plasma separators
5.1.2.2 Plasma component separators
5.1.2.3 Immunoadsorption Columns
5.1.2.4 Plasma Perfusion Columns
5.1.2.5 Hemoperfusion Columns
5.1.3 Apheresis disposables
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Procedure
5.2.1 Introduction
5.2.2 Donor Apheresis
5.2.3 Therapeutic Apheresis
5.2.4 Y-o-Y Growth Analysis, By Procedure
5.2.5 Market Attractiveness Analysis, By Procedure
5.2.6 Market Share Analysis, By Procedure
5.3 Application
5.3.1 Introduction
5.3.2 Renal Diseases
5.3.3 Neurology
5.3.4 Cancer
5.3.5 Hematology
5.3.6 Autoimmune Diseases
5.3.7 Cardiovascular Diseases
5.3.8 Y-o-Y Growth Analysis, By Application
5.3.9 Market Attractiveness Analysis, By Application
5.3.10 Market Share Analysis, By Application
5.4 Technology
5.4.1 Centrifugation
5.4.1.1 Intermittent Flow
5.4.1.2 Continuous Flow
5.4.2 Membrane Separation
5.4.3 Y-o-Y Growth Analysis, By Technology
5.4.4 Market Attractiveness Analysis, By Technology
5.4.5 Market Share Analysis, By Technology
5.5 End user
5.5.1 Introduction
5.5.2 Private Blood Collection Centres
5.5.3 Public Blood Collection Centres
5.5.4 Hospitals
5.4.5 Y-o-Y Growth Analysis, By End user
5.4.6 Market Attractiveness Analysis, By End user
5.4.7 Market Share Analysis, By End user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Procedure
6.1.3.4 By Application
6.1.3.5 By Technology
6.1.3.6 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Procedure
6.1.4.4 By Application
6.1.4.5 By Technology
6.1.4.6 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Procedure
6.1.5.4 By Application
6.1.5.5 By Itechnology
6.1.5.6 By End user
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Asahi Kasei Medical Co., Ltd.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Haemonetics Corporation
8.3 Terumo BCT, Inc.
8.4 Fresenius Medical Care
8.5 Kawasumi Laboratories Inc.
8.6 Cerus Corporation
8.7 Hemacare Corporation
8.8 Kaneka Corporation
8.9 Braun Melsungen AG
8.10 Nikkiso Co., Ltd.
8.11 Therakos, Inc.,
8.12 Medica S.p.A.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
Apr 2021
Apr 2021
